Provisional Agenda
(Subject to change: The conference may finish earlier or later than the advertised times each day)
Event type: Virtual/in-person hybrid
Presentation language: English
Venue: The Jarvis Doctorow Hall, St Edmund Hall, Queen’s Lane, Oxford, UK
Time Zone: All times mentioned refer to British Standard (BST) – London/GMT +01:00.
Password and links: Registered conference delegates will be sent joining information and conference access links a few days before the conference.
World Time Converter: https://greenwichmeantime.com/time-gadgets/time-zone-converter | https://greenwichmeantime.com/timepiece/world-clock | https://www.worldtimebuddy.com
NB: Due to the hybrid nature of the agenda and the wide geographical locations of our speakers, it may not always be possible to group related presentations together.
Day 1, 26th August
1330: Registration
1425: Welcome and housekeeping
1430: Professor Sir David Warrell
Professor Emeritus, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Welcome to the University of Oxford and Remembering John B Harris
Session 1: Latin America – Chair Dr Stefanie Menzies
1440: Professor Nelson Jorge da Silva, Jr
Professor, Pontifical Catholic University of Goiás, School of Medical and Life Sciences, Graduate Program in Environmental and Health Sciences, Goiânia, Goiás, Brazil
Clinical silence, taxonomy, and toxinology complexity: the underestimated significance of coral snake envenomations in Brazil
1510: Refreshments, networking and posters
1540: Professor Denise Tambourgi
Professor, Laboratory of Biochemistry, Laboratory of Immunopathology, Butantan Institute, São Paulo, Brazil
Premolis semirufa and pararamosis: mechanisms of chronic joint inflammation and tissue damage
1610: Professor Jacqueline de Almeida Gonçalves Sachett (V)
Professor, School of Health Sciences, University of the State of Amazonas, Brazil
Treatments Ancillary to Antivenom in Snakebite: Impact on Functional Outcomes and Disability
1640: Professor José María Gutiérrez (V)
Professor, Instituto Clodomiro Picado, Facultad de Microbiología, Universidad de Costa Rica, San José, Costa Rica
Thrombocytopenia induced by viperid snake venoms in a murine model and its neutralization by antivenoms
1710: Mrs Khushboo Daga and Mr Siddharth Daga
Chief Executive Officer and Managing Director, VINS Bioproducts Ltd, Telangana, India
An Introduction to VINS Bioproducts
1720: End of Day 1
Day 2, 27th August
Session 2: Toxins and poisons – Chair Professor Sir David Warrell
0900: Citation and presentation of Lifetime Achievement Award to Glenn F King by Professor David Warrell
0920: Professor Glenn King
Professor, Institute for Molecular Bioscience, The University of Queensland, Brisbane QLD, Australia
Gain from pain: spider venoms as a source of non-addictive analgesics
0950: Professor Thomas Platts-Mills
Professor of Medicine and Microbiology, Division of Allergy and Clinical Immunology, School of Medicine, University of Virginia, Virginia, USA
A collision between tick bites and snake bites: IgE antibodies specific for galactose alpha-1,3-galactose and allergic reactions to antivenom
1020-1120: Refreshments, networking + poster session
Session 2: Toxins and poisons – Chair Dr Ron Jenner
1120: Dr Michelle Khai Khun Yap (V)
Senior Lecturer and Program Director of Medical Bioscience, School of Science, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
Proteomics- and machine-learning-guided identification of biomarkers associated with cobra venom cytotoxin-induced cell death
1140: Dr Krzysztof Kowalski (V)
Assistant Professor, Department of Vertebrate Zoology and Ecology, Institute of Biology, Faculty of Biological and Veterinary Sciences, Nicolaus Copernicus University in Toruń, Toruń, Poland
Metabolic costs of poison production in the common toad, Bufo bufo
1200: Professor Cesare Montecucco
Professor Emeritus, Department of Biomedical Sciences, University of Padova and Institute of Neuroscience, National Research Council, Padova, Italy
Botulinum toxins impair the enteric nervous system lowering intestinal defense
1230: Professor Elaine Fitches
Professor, School of Biosciences, University of Durham, Durham, UK
A dual ICK-GNA chimera combining the spider venom neurotoxin ω-Hexatoxin-Hv1a and pea seed albumin PA1b peptide exhibits synergised biopesticidal activity
1250: Dr Yuqi Reitsema-Wang
Postdoctoral Scientist, Department of Zoology, University of Cambridge, Cambridge, UK
The dynamic of scorpion venom as a social transfer in sexual contexts: a multi-omic study in Hadrurus arizonensis
1310: Lunch and networking
1410: Dr Stefanie Menzies
Lecturer in Molecular Cell Biology, Biomedical & Life Sciences, Lancaster University, UK
Novel C-type lectin-like proteins from Echis romani venom
Session 3: Antivenoms – Chair Dr Tim Platts-Mills
1440: Dr Nick Burlet
Postdoctoral Scientist, Department of Biotechnology and Biomedicine, Technical University of Denmark, DK-2700 Kongens Lyngby, Denmark
Discovery of broadly-neutralizing recombinant single domain antibodies for treatment of snakebite envenoming
1500: Dr Sheikh Mohammed Arif
Postdoctoral Scientist, Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Rd, Cambridge, UK
Generation of immune-derived Naja PLA2-neutralising recombinant antibodies by phage display
1520: Dr Rhys Dunphy
Postdoctoral Scientist, Department of Medicine, University of Cambridge, Addenbrookes Hospital, Hills Rd, Cambridge, UK
Generation of neutralising recombinant antibodies against an Echis ocellatus SVMP-III isoform from immune derived phage display libraries
1540: Refreshments, networking and posters
1610: Dr Abdullah Abu Sayeed
Assistant Professor, Department of Medicine, Chittagong Medical College, Chattogram, Bangladesh
Monovalent Avian Antibodies for Snakebite Envenoming: First Local Production and Preclinical Evidence from Bangladesh
1630: Professor Juan Calvete
Professor, Instituto de Biomedicina de Valencia, Valencia, Spain
Building bridges between Elapiland, Viperiland, and Colubriland
1650: Dr Alan de Lima Pereira (V)
Principle Investigator, Medecins Sans Frontieres, 14 Plantage Middenlaan, Amsterdam, Nord Holland 1018 DD, Netherlands
Polyvalent antivenom for snakebite envenoming in Ethiopia: a prospective cohort study
1710: End of Day 2
1900: Networking dinner (further information to follow)
Day 3, 28th August
0830: Accommodation checkout
Session 4: Clinical toxinology – Chair Dr David Williams
0900: Professor Sir David Warrell
Professor Emeritus, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK
Decline and Fall of Clinical Toxinology
0920: Dr David Williams
Executive Director, Global Snakebite Initiative USA Foundation, Belmont, California, USA.
First Aid, Fallacy or Fabrication – Sutherland’s Pressure Immobilisation Bandage Technique
0950: Professor Abdulrazzaq Habib – Daga Sr Keynote (sponsored by VINS Bioproducts, India)
Professor of Medicine, Department of Internal Medicine, Faculty of Clinical Sciences, Bayero University Kano, Nigeria
Utility of Prospective Registry and ‘Big’ Data for Snakebite Management in Nigeria
1020: Dr Thomas Lamb
Consultant Physician, Department of infectious Diseases, North Manchester General Hospital, Manchester University NHS Foundation Trust, Manchester, UK
Understanding the role of cell free heme causing acute kidney injury following snakebite in India
1040: Refreshments, networking and posters
Session 5: Venom enzyme inhibitors for treating snakebite envenoming – Chair Professor Juan Calvete
1100: Dr Tim Platts-Mills
CMO, Ophirex, Inc, Paradise Drive, Corte Madera, CA, USA
Lessons Learned from Two Clinical Trials of Varespladib: Building a Framework for Evaluating Novel Snakebite Therapies
1120: Dr Madison McGann
Investigator, Department of Emergency Medicine, Duke University, Durham, NC 27708, USA
Effects of Varespladib for Cytotoxic, PLA2-rich, Agkistrodon contortrix Envenoming: A Secondary Analysis of Results from Two Randomized Controlled Trials
1140: Dr Joao Vissoci
Investigator, Department of Emergency Medicine, Duke University, Durham, NC, USA
Association of Snakebite Severity and Functional Recovery in a Multinational Randomized Clinical Trial
1200: Dr Cecilie Knudsen
Postdoctoral Scientist, Digital Biotechnology Lab, Department of Bioengineering, Technical University of Denmark, Kongens Lyngby, Storkøbenhavn, Denmark
In silico design of polyspecific minibinders targeting snake venom phospholipase A2s
1220: Final discussion, networking and departure
